NYSE American - Nasdaq Real Time Price USD

NovaBay Pharmaceuticals, Inc. (NBY)

0.0806 +0.0036 (+4.68%)
As of 3:10 PM EDT. Market Open.
All All Favorites Text Statistics Technicals Fibonacci Markings Lines
Loading Chart for NBY

Recent News: NBY

View More

NovaBay Pharmaceuticals Announces New and Enhanced Direct-to-Consumer Marketing to Efficiently Engage Customers and Drive Avenova Sales
Business Wire 4 days ago
NovaBay Pharmaceuticals Receives a NYSE American Notice Regarding Stockholder Equity

NovaBay Pharmaceuticals Receives a NYSE American Notice Regarding Stockholder Equity
Business Wire 6 days ago

NovaBay Pharmaceuticals Reports Preliminary Eyecare and Wound Care Revenue Increased 13% for the First Quarter of 2024 on Lower Sales and Marketing Expenses
Business Wire 9 days ago
NovaBay Pharmaceuticals, Inc. (AMEX:NBY) Q4 2023 Earnings Call Transcript

NovaBay Pharmaceuticals, Inc. (AMEX:NBY) Q4 2023 Earnings Call Transcript
Insider Monkey 30 days ago

Q4 2023 NovaBay Pharmaceuticals Inc Earnings Call
Thomson Reuters StreetEvents 30 days ago

NovaBay Pharmaceuticals Reports 2023 Fourth Quarter and Full Year Financial Results
Business Wire 30 days ago

NovaBay Pharmaceuticals to Hold 2023 Fourth Quarter and Full Year Conference Call on March 26, 2024
Business Wire last month

NovaBay Pharmaceuticals Announces Agreement to Sell its DERMAdoctor Skincare Business Segment; Announces Preliminary Financial Results for Fourth Quarter and Year Ended December 31, 2023
Business Wire last month
NovaBay Pharmaceuticals and Eyenovia to Co-Promote Prescription Ophthalmic Products to U.S. Eyecare Professionals

NovaBay Pharmaceuticals and Eyenovia to Co-Promote Prescription Ophthalmic Products to U.S. Eyecare Professionals
GlobeNewswire last month

NovaBay Pharmaceuticals Reports 64% Year-Over-Year Growth in Avenova Unit Subscription-Based Sales
Business Wire 2 months ago
NovaBay Pharmaceuticals and Sonoma Pharmaceuticals Agree to Market Avenova-branded Products in the European Union Through Sonoma’s Extensive Distributor Network

NovaBay Pharmaceuticals and Sonoma Pharmaceuticals Agree to Market Avenova-branded Products in the European Union Through Sonoma’s Extensive Distributor Network
ACCESSWIRE 3 months ago

NovaBay Pharmaceuticals Partners with Woo University to Educate Eyecare Professionals on the Use of Amniotic Membranes
Business Wire 4 months ago
View More

Related Tickers

ELAB Elevai Labs, Inc.
0.6577
-2.42%
 
ATXI Avenue Therapeutics, Inc.
7.33
-16.47%
 
ASLN ASLAN Pharmaceuticals Limited
0.4300
-3.97%
 
KTRA Kintara Therapeutics, Inc.
0.1410
-10.76%
 
ALLR Allarity Therapeutics, Inc.
1.4800
+3.55%
 
GRTS Gritstone bio, Inc.
0.8134
+6.40%
 
PRTG Portage Biotech Inc.
0.2630
+4.08%
 
PSTV Plus Therapeutics, Inc.
1.6701
+0.61%
 
RNAZ TransCode Therapeutics, Inc.
0.5327
+1.99%
 
INM InMed Pharmaceuticals Inc.
0.2392
-5.59%